UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

EPCORITAMAB WITH RITUXIMAB + LENALIDOMIDE (R2) PROVIDES DURABLE RESPONSES IN HIGH‐RISK FOLLICULAR LYMPHOMA, REGARDLESS OF POD24 STATUS

Hematological oncology, 2023-06, Vol.41 (S2), p.125-127

2023

Volltextzugriff (PDF)

Assessing the thrombotic risk of patients with essential thrombocythemia in the genomic era

Leukemia, 2017-09, Vol.31 (9), p.1845-1854

2017

Volltextzugriff (PDF)

Lesions of the prepuce and penis in rams: A retrospective study

Veterinary research communications, 2023-12, Vol.47 (4), p.2259-2264

2023

Volltextzugriff (PDF)

Incidence and prognostic impact of other cancers in a population of long-term survivors of chronic lymphocytic leukemia

Annals of oncology, 2016-06, Vol.27 (6), p.1100-1106

2016

Volltextzugriff (PDF)

OC05.02: External validation of ultrasound‐based prediction models for discrimination between benign and malignant adnexal masses in Italy: IOTA phase 6 study

Ultrasound in obstetrics & gynecology, 2024-09, Vol.64 (S1), p.12-13

2024

Volltextzugriff (PDF)

Genome-wide association study for residual concentrate intake using different approaches in Italian Brown Swiss

Italian journal of animal science, 2021-01, Vol.20 (1), p.1957-1967

2021

Volltextzugriff (PDF)

An in vitro investigation of the actions of reproductive hormones on the cervix of the ewe in the follicular stage: The effects of 17β-estradiol, oxytocin, FSH, and arachidonic acid on the cervical pathway for the synthesis of prostaglandin E2

Theriogenology, 2015-04, Vol.83 (6), p.1007-1014

2015

Volltextzugriff (PDF)

ETV6-FLT3 fusion gene-positive, eosinophilia-associated myeloproliferative neoplasm successfully treated with sorafenib and allogeneic stem cell transplant

Leukemia, 2014-10, Vol.28 (10), p.2090-2092

2014

Volltextzugriff (PDF)

HIGH COMPLETE METABOLIC RESPONSE RATES WITH EPCORITAMAB + R‐CHOP IN PREVIOUSLY UNTREATED (1L) HIGH‐RISK DLBCL, INCLUDING DOUBLE‐HIT/TRIPLE‐HIT: EPCORE NHL‐2 UPDATE

Hematological oncology, 2023-06, Vol.41 (S2), p.207-208

2023

Volltextzugriff (PDF)

Radiotherapy as an effective bridge for chemo‐refractory or progressive secondary CNS lymphoma

Hematological oncology, 2023-06, Vol.41 (S2), p.406-407

2023

Volltextzugriff (PDF)

Cerium oxide nanoparticles (CeO 2 NPs) improve the developmental competence of in vitro-matured prepubertal ovine oocytes

Reproduction fertility and development, 2017-04, Vol.29 (5), p.1046

2017

Volltextzugriff (PDF)

The expression of ERα, OTR, cPLA(2), COX-2, and PPARγ in the cervix of the ewe during the estrous cycle

Theriogenology, 2013-01, Vol.79 (1), p.40-47

2013

Volltextzugriff (PDF)

The expression of ERα, OTR, cPLA2, COX-2, and PPARγ in the cervix of the ewe during the estrous cycle

Theriogenology, 2013, Vol.79 (1), p.40-47

2013

Volltextzugriff (PDF)

CNS radiotherapy as bridging prior to CAR T‐cell therapy for hematologic malignancies

Hematological oncology, 2023-06, Vol.41 (S2), p.530-532

2023

Volltextzugriff (PDF)

GLOFITAMAB MONOTHERAPY IN PATIENTS WITH RELAPSED/REFRACTORY (R/R) LARGE B‐CELL LYMPHOMA (LBCL): EXTENDED FOLLOW‐UP AND LANDMARK ANALYSES FROM A PIVOTAL PHASE II STUDY

Hematological oncology, 2023-06, Vol.41 (S2), p.144-146

2023

Volltextzugriff (PDF)

Tyrosine kinase inhibitors

Current cancer drug targets, 2010-08, Vol.10 (5), p.462-483

2010

Volltextzugriff (PDF)

PET‐Adapted Therapy with Nivolumab plus Adriamycin, Vinblastine, and Dacarbazine for Newly Diagnosed Stage III or IV Hodgkin Lymphoma

Hematological oncology, 2023-06, Vol.41 (S2), p.351-353

2023

Volltextzugriff (PDF)

PHASE 2 TRIAL OF NIVOLUMAB PLUS ADRIAMYCIN, VINBLASTINE, DACARBAZINE (N‐AVD) AS FRONTLINE THERAPY IN OLDER ADULTS WITH HODGKIN LYMPHOMA

Hematological oncology, 2023-06, Vol.41 (S2), p.161-162

2023

Volltextzugriff (PDF)

THE COMBINATION OF DUVELISIB AND ROMIDEPSIN (DR) IS HIGHLY ACTIVE AGAINST RELAPSED/REFRACTORY PERIPHERAL T‐CELL LYMPHOMA WITH LOW RATES OF TRANSAMINITIS: FINAL RESULTS

Hematological oncology, 2021-06, Vol.39 (S2)

2021

Volltextzugriff (PDF)

P1135: SUBCUTANEOUS EPCORITAMAB IN COMBINATION WITH RITXUIMAB + LENALIDOMIDE IN RELAPSED OR REFRACTORY FOLLICULAR LYMPHOMA: PHASE 1/2 TRIAL UPDATE

HemaSphere, 2022-06, Vol.6 (Suppl), p.1025-1026

2022

Volltextzugriff (PDF)

P1215: PRELIMINARY PHASE 1/2 RESULTS OF SUBCUTANEOUS EPCORITAMAB + R‐DHAX/C IN PATIENTS WITH RELAPSED OR REFRACTORY DIFFUSE LARGE B‐CELL LYMPHOMA ELIGIBLE FOR AUTOLOGOUS STEM CELL TRANSPLANT

HemaSphere, 2022-06, Vol.6 (Suppl), p.1101-1102

2022

Volltextzugriff (PDF)

P1214: SUBCUTANEOUS EPCORITAMAB + R‐CHOP FOR FIRST‐LINE TREATMENT OF PATIENTS WITH HIGH‐RISK DIFFUSE LARGE B‐CELL LYMPHOMA: PHASE 1/2 UPDATE

HemaSphere, 2022-06, Vol.6 (Suppl), p.1100-1101

2022

Volltextzugriff (PDF)

CLINICAL OUTCOMES AND THE ROLE OF OBSERVATION IN EARLY‐STAGE FOLLICULAR LYMPHOMA

Hematological oncology, 2021-06, Vol.39 (S2)

2021

Volltextzugriff (PDF)

The pattern of cervical penetration and the effect of topical treatment with prostaglandin and/or FSH and oxytocin on the depth of cervical penetration in the ewe during the peri-ovulatory period

Theriogenology, 2012-07, Vol.78 (2), p.376-384

2012

Volltextzugriff (PDF)

TARGETING THE PERIPHERAL T‐CELL LYMPHOMA (PTCL) EPIGENOME WITH ORAL 5‐AZACYTIDINE AND ROMIDEPSIN: RESULTS AND CLINICAL‐MOLECULAR CORRELATIONS FROM A PHASE 2 STUDY

Hematological oncology, 2019-06, Vol.37 (S2), p.178-179

2019

Volltextzugriff (PDF)

1 – 25 von 336

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(272)
Mit Volltextzugriff
(254)

Publikationsform

1 weiteren anzeigen...

Weniger anzeigen...

Sprache

1 weiteren anzeigen...

Weniger anzeigen...

Erscheinungsjahr

n.n

Thema

Science & Technology
(164)
Humans
(139)
Life Sciences & Biomedicine
(133)
Female
(74)
Male
(67)
Middle Aged
(61)
Adult
(59)
Biological And Medical Sciences
(48)
Medical Sciences
(40)
Aged
(39)
Animals
(25)
Life Sciences
(24)
Genetics & Heredity
(20)
Adolescent
(19)
Genetics
(19)
Physical Sciences
(19)
Technology
(17)
Aged, 80 And Over
(16)
Fundamental And Applied Biological Sciences. Psychology
(16)
Hematology
(16)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(5)
... seit 90 Tagen
(8)

Menü

Weitere Dienste

Einstellungen

EPCORITAMAB WITH RITUXIMAB + LENALIDOMIDE (R2) PROVIDES DURABLE RESPONSES IN HIGH‐RISK FOLLICULAR LYMPHOMA, REGARDLESS OF POD24 STATUS

Assessing the thrombotic risk of patients with essential thrombocythemia in the genomic era

Lesions of the prepuce and penis in rams: A retrospective study

Incidence and prognostic impact of other cancers in a population of long-term survivors of chronic lymphocytic leukemia

OC05.02: External validation of ultrasound‐based prediction models for discrimination between benign and malignant adnexal masses in Italy: IOTA phase 6 study

Genome-wide association study for residual concentrate intake using different approaches in Italian Brown Swiss

An in vitro investigation of the actions of reproductive hormones on the cervix of the ewe in the follicular stage: The effects of 17β-estradiol, oxytocin, FSH, and arachidonic acid on the cervical pathway for the synthesis of prostaglandin E2

ETV6-FLT3 fusion gene-positive, eosinophilia-associated myeloproliferative neoplasm successfully treated with sorafenib and allogeneic stem cell transplant

HIGH COMPLETE METABOLIC RESPONSE RATES WITH EPCORITAMAB + R‐CHOP IN PREVIOUSLY UNTREATED (1L) HIGH‐RISK DLBCL, INCLUDING DOUBLE‐HIT/TRIPLE‐HIT: EPCORE NHL‐2 UPDATE

Radiotherapy as an effective bridge for chemo‐refractory or progressive secondary CNS lymphoma

Cerium oxide nanoparticles (CeO 2 NPs) improve the developmental competence of in vitro-matured prepubertal ovine oocytes

The expression of ERα, OTR, cPLA(2), COX-2, and PPARγ in the cervix of the ewe during the estrous cycle

The expression of ERα, OTR, cPLA2, COX-2, and PPARγ in the cervix of the ewe during the estrous cycle

CNS radiotherapy as bridging prior to CAR T‐cell therapy for hematologic malignancies

GLOFITAMAB MONOTHERAPY IN PATIENTS WITH RELAPSED/REFRACTORY (R/R) LARGE B‐CELL LYMPHOMA (LBCL): EXTENDED FOLLOW‐UP AND LANDMARK ANALYSES FROM A PIVOTAL PHASE II STUDY

Tyrosine kinase inhibitors

PET‐Adapted Therapy with Nivolumab plus Adriamycin, Vinblastine, and Dacarbazine for Newly Diagnosed Stage III or IV Hodgkin Lymphoma

PHASE 2 TRIAL OF NIVOLUMAB PLUS ADRIAMYCIN, VINBLASTINE, DACARBAZINE (N‐AVD) AS FRONTLINE THERAPY IN OLDER ADULTS WITH HODGKIN LYMPHOMA

THE COMBINATION OF DUVELISIB AND ROMIDEPSIN (DR) IS HIGHLY ACTIVE AGAINST RELAPSED/REFRACTORY PERIPHERAL T‐CELL LYMPHOMA WITH LOW RATES OF TRANSAMINITIS: FINAL RESULTS

P1135: SUBCUTANEOUS EPCORITAMAB IN COMBINATION WITH RITXUIMAB + LENALIDOMIDE IN RELAPSED OR REFRACTORY FOLLICULAR LYMPHOMA: PHASE 1/2 TRIAL UPDATE

P1215: PRELIMINARY PHASE 1/2 RESULTS OF SUBCUTANEOUS EPCORITAMAB + R‐DHAX/C IN PATIENTS WITH RELAPSED OR REFRACTORY DIFFUSE LARGE B‐CELL LYMPHOMA ELIGIBLE FOR AUTOLOGOUS STEM CELL TRANSPLANT

P1214: SUBCUTANEOUS EPCORITAMAB + R‐CHOP FOR FIRST‐LINE TREATMENT OF PATIENTS WITH HIGH‐RISK DIFFUSE LARGE B‐CELL LYMPHOMA: PHASE 1/2 UPDATE

CLINICAL OUTCOMES AND THE ROLE OF OBSERVATION IN EARLY‐STAGE FOLLICULAR LYMPHOMA

The pattern of cervical penetration and the effect of topical treatment with prostaglandin and/or FSH and oxytocin on the depth of cervical penetration in the ewe during the peri-ovulatory period

TARGETING THE PERIPHERAL T‐CELL LYMPHOMA (PTCL) EPIGENOME WITH ORAL 5‐AZACYTIDINE AND ROMIDEPSIN: RESULTS AND CLINICAL‐MOLECULAR CORRELATIONS FROM A PHASE 2 STUDY

Suchergebnisse filtern